chlorpromazine has been researched along with galantamine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Arce, MP; Conde, S; del Barrio, L; Egea, J; García, AG; González-Muñoz, GC; León, R; López, B; López, MG; Martín-de-Saavedra, MD; Pérez, C; Rodríguez-Franco, MI; Romero, A; Villarroya, M | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Mil'shteĭn, GI; Zaostrovskiĭ, OV | 1 |
| Shmatkov, YV | 1 |
| Strokina, TI | 1 |
| Komissarova, RA | 1 |
| Popova, EN | 1 |
| Kozlova, TA | 1 |
1 review(s) available for chlorpromazine and galantamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
13 other study(ies) available for chlorpromazine and galantamine
| Article | Year |
|---|---|
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
N-acylaminophenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antineoplastic Agents; Butyrylcholinesterase; Calcium; Cell Death; Cell Survival; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Okadaic Acid; Peptide Fragments; Phenothiazines; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[The effect of neutotropic substances on motor excitation in dogs induced by amizil].
Topics: Animals; Benactyzine; Chlorpromazine; Diazepam; Dogs; Drug Interactions; Female; Galantamine; Haloperidol; Male; Motor Activity; Perphenazine; Promazine; Psychotropic Drugs | 1975 |
Bioelectric activity and haemodynamics during drug effects in hypotonic patients.
Topics: Adolescent; Adult; Amphetamine; Cerebral Cortex; Chlorpromazine; Electroencephalography; Female; Galantamine; Hemodynamics; Humans; Hypotension; Iproniazid; Methysergide; Psyllium | 1970 |
[Electroencephalographic analysis of the effect of some neurotropic drugs on the mediator brain structures in patients with Kozhevnikov's epilepsy].
Topics: Adult; Amphetamine; Benactyzine; Chlorpromazine; Electroencephalography; Epilepsy; Galantamine; Humans; Iproniazid; Lysergic Acid Diethylamide; Male; Niacinamide | 1970 |
[On the mechanism of the sedative effect of lithium carbonate].
Topics: Amphetamine; Animals; Brain Chemistry; Chlorpromazine; Drug Synergism; Galantamine; Iproniazid; Lithium; Potassium; Rats; Reflex; Sensation; Serotonin; Sodium | 1966 |
On the effect of some neuropharmacological agents on the structure of neurons of various cyto-architectonic formations.
Topics: Animals; Behavior, Animal; Brain; Brain Stem; Cerebral Cortex; Chlorpromazine; Galantamine; Geniculate Bodies; Hypothalamus; Male; Mesencephalon; Neurons; Rats; Reticular Formation; Tectum Mesencephali; Thalamus | 1967 |
[Etiology, pathogenesis and treatment of tics in children].
Topics: Adolescent; Benactyzine; Child; Child, Preschool; Chlorpromazine; Female; Galantamine; Humans; Levodopa; Male; Neurocognitive Disorders; Neurologic Examination; Neurotic Disorders; Tic Disorders | 1980 |